Missense mutations in the human glutathione synthetase gene result in severe metabolic acidosis, 5-oxoprolinuria, hemolytic anemia and neurological dysfunction. 1997

N Dahl, and M Pigg, and E Ristoff, and R Gali, and B Carlsson, and B Mannervik, and A Larsson, and P Board
Department of Clinical Genetics, Uppsala University Children's Hospital, Sweden. niklas.dahl@klingen.uu.se

Severe glutathione synthetase (GS) deficiency is a rare genetic disorder with neonatal onset. The enzymatic block of the gamma-glutamyl cycle leads to a generalized glutathione deficiency. Clinically affected patients present with severe metabolic acidosis, 5-oxoprolinuria, increased rate of hemolysis and defective function of the central nervous system. The disorder is inherited in an autosomal recessive mode and, until recently, the molecular basis has remained unknown. We have sequenced 18 GS alleles associated with enzyme deficiency and we detected missense mutations by direct sequencing of cDNAs and genomic DNA. In total, 13 different mutations were identified. Four patients were found to be compound heterozygotes and two individuals were apparently homozygous. Reduced enzymatic activities were demonstrated in recombinant protein expressed from cDNAs in four cases with different missense mutations. The results from biochemical analysis of patient specimens, supported by the properties of the expressed mutant proteins, indicate that a residual activity is present in affected individuals. Our results suggest that complete loss of function of both GS alleles is probably lethal. It is postulated that missense mutations will account for the phenotype in the majority of patients with severe GS deficiency.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009422 Nervous System Diseases Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle. Neurologic Disorders,Nervous System Disorders,Neurological Disorders,Disease, Nervous System,Diseases, Nervous System,Disorder, Nervous System,Disorder, Neurologic,Disorder, Neurological,Disorders, Nervous System,Disorders, Neurologic,Disorders, Neurological,Nervous System Disease,Nervous System Disorder,Neurologic Disorder,Neurological Disorder
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011761 Pyrrolidonecarboxylic Acid A cyclized derivative of L-GLUTAMIC ACID. Elevated blood levels may be associated with problems of GLUTAMINE or GLUTATHIONE metabolism. 5-Oxoproline,Pidolic Acid,Pyroglutamic Acid,5-Ketoproline,5-Oxopyrrolidine-2-Carboxylic Acid,Magnesium Pidolate,Pyroglutamate,Pidolate, Magnesium
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005981 Glutathione Synthase One of the enzymes active in the gamma-glutamyl cycle. It catalyzes the synthesis of glutathione from gamma-glutamylcysteine and glycine in the presence of ATP with the formation of ADP and orthophosphate. EC 6.3.2.3. Glutathione Synthetase,Synthase, Glutathione,Synthetase, Glutathione
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

N Dahl, and M Pigg, and E Ristoff, and R Gali, and B Carlsson, and B Mannervik, and A Larsson, and P Board
November 1996, Nature genetics,
N Dahl, and M Pigg, and E Ristoff, and R Gali, and B Carlsson, and B Mannervik, and A Larsson, and P Board
February 2015, Fetal and pediatric pathology,
N Dahl, and M Pigg, and E Ristoff, and R Gali, and B Carlsson, and B Mannervik, and A Larsson, and P Board
April 2023, The American journal of case reports,
N Dahl, and M Pigg, and E Ristoff, and R Gali, and B Carlsson, and B Mannervik, and A Larsson, and P Board
October 1983, Blood,
N Dahl, and M Pigg, and E Ristoff, and R Gali, and B Carlsson, and B Mannervik, and A Larsson, and P Board
January 1992, Journal of inherited metabolic disease,
N Dahl, and M Pigg, and E Ristoff, and R Gali, and B Carlsson, and B Mannervik, and A Larsson, and P Board
June 2001, Journal of inherited metabolic disease,
N Dahl, and M Pigg, and E Ristoff, and R Gali, and B Carlsson, and B Mannervik, and A Larsson, and P Board
July 2001, Acta paediatrica (Oslo, Norway : 1992),
N Dahl, and M Pigg, and E Ristoff, and R Gali, and B Carlsson, and B Mannervik, and A Larsson, and P Board
July 2019, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine,
N Dahl, and M Pigg, and E Ristoff, and R Gali, and B Carlsson, and B Mannervik, and A Larsson, and P Board
November 2015, Brain & development,
N Dahl, and M Pigg, and E Ristoff, and R Gali, and B Carlsson, and B Mannervik, and A Larsson, and P Board
March 2012, British journal of clinical pharmacology,
Copied contents to your clipboard!